Northover AM |
Modification by some antagonists of the shape changes of venous endothelial cells in response to inflammatory agents in vitro. |
1990 |
Agents Actions |
pmid:2111079
|
Jouquey S et al. |
Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat. |
1988 |
Agents Actions |
pmid:2459935
|
Sanchez Crespo M and Nieto ML |
Modulation of PAF biosynthesis in human polymorphonuclear leukocytes. The role of phorbol esters and protein kinases. |
1989 |
Agents Actions |
pmid:2711927
|
Nieminen MM et al. |
Body temperature modulates the effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit. |
1991 |
Agents Actions |
pmid:1862740
|
Jenei B et al. |
Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function). |
1991 |
Agents Actions |
pmid:1862750
|
Carlson RP et al. |
Pharmacologic modulation of PAF-induced mortality in mice. |
1987 |
Agents Actions |
pmid:3120513
|
Raff GW et al. |
Procoagulant property of platelet activating factor (PAF). |
1993 |
Agents Actions |
pmid:8273543
|
Meats JE et al. |
Identification of phospholipase D (PLD) activity in mouse peritoneal macrophages. |
1993 |
Agents Actions |
pmid:8273553
|
Thomas TK et al. |
Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat. |
1993 |
Agents Actions |
pmid:8273566
|
Glaser KB et al. |
Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2). |
1993 |
Agents Actions |
pmid:8273577
|
Mencia-Huerta JM et al. |
Is platelet-activating factor (PAF-acether) synthesis by murine peritoneal cells (PC) a two-step process? |
1981 |
Agents Actions |
pmid:7053072
|
Borrel MC et al. |
Additional techniques for the total synthesis of PAF-acether. |
1982 |
Agents Actions |
pmid:7164944
|
Benveniste J et al. |
Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types. |
1982 |
Agents Actions |
pmid:7164945
|
Arnoux B et al. |
Release of PAF-acether from human blood monocytes. |
1982 |
Agents Actions |
pmid:7164946
|
Fouque F et al. |
Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action. |
1982 |
Agents Actions |
pmid:7164947
|
Bonnet J et al. |
Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes. |
1981 |
Agents Actions |
pmid:7340441
|
Denjean A et al. |
Bronchoconstriction induced by intratracheal administration of platelet-activating factor (PAF-acether) in baboons. |
1981 |
Agents Actions |
pmid:7340444
|
Louis R et al. |
Potentiation of histamine release from human leucocytes by PAF. |
1994 |
Agents Actions |
pmid:7521570
|
Kelefiotis D and Vakirtzi-Lemonias C |
In vivo responses of mouse blood cells to platelet-activating factor (PAF): role of the mediators of anaphylaxis. |
1993 |
Agents Actions |
pmid:8023738
|
Northover AM and Northover BJ |
Involvement of protein kinase C in the control of microvascular permeability to colloidal carbon. |
1993 |
Agents Actions |
pmid:8304240
|